Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards clinical grating-interferometry mammography.
Arboleda C, Wang Z, Jefimovs K, Koehler T, Van Stevendaal U, Kuhn N, David B, Prevrhal S, Lång K, Forte S, Kubik-Huch RA, Leo C, Singer G, Marcon M, Boss A, Roessl E, Stampanoni M. Arboleda C, et al. Among authors: lang k. Eur Radiol. 2020 Mar;30(3):1419-1425. doi: 10.1007/s00330-019-06362-x. Epub 2019 Aug 22. Eur Radiol. 2020. PMID: 31440834 Free PMC article.
Correction to: Towards clinical grating-interferometry mammography.
Arboleda C, Wang Z, Jefimovs K, Koehler T, Van Stevendaal U, Kuhn N, David B, Prevrhal S, Lång K, Forte S, Kubik-Huch RA, Leo C, Singer G, Marcon M, Boss A, Roessl E, Stampanoni M. Arboleda C, et al. Among authors: lang k. Eur Radiol. 2020 Mar;30(3):1823. doi: 10.1007/s00330-019-06476-2. Eur Radiol. 2020. PMID: 31897597 Free PMC article.
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K, Josefsson V, Larsson AM, Larsson S, Högberg C, Sartor H, Hofvind S, Andersson I, Rosso A. Lång K, et al. Lancet Oncol. 2023 Aug;24(8):936-944. doi: 10.1016/S1470-2045(23)00298-X. Lancet Oncol. 2023. PMID: 37541274 Clinical Trial.
Organizational impact of systemic implementation of digital breast tomosynthesis as a primary test for breast cancer screening in Italy.
Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, Vecchio R, Bucchi L, Senore C, Giordano L, Paci E, Bonifacino A, Calabrese M, Caumo F, Degrassi F, Sassoli De' Bianchi P, Battisti F, Zappa M, Pattacini P, Campari C, Nitrosi A, Di Leo G, Frigerio A, Magni V, Fornasa F, Romanucci G, Falini P, Auzzi N, Armaroli P, Giorgi Rossi P; MAITA working group; Italian Breast Cancer Screening Guidelines working group. Djuric O, et al. Radiol Med. 2024 Aug;129(8):1156-1172. doi: 10.1007/s11547-024-01849-0. Epub 2024 Jul 23. Radiol Med. 2024. PMID: 39042203
Budget impact analysis of introducing digital breast tomosynthesis in breast cancer screening in Italy.
Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, Vecchio R, Bucchi L, Senore C, Giordano L, Paci E, Bonifacino A, Calabrese M, Caumo F, Degrassi F, Sassoli De' Bianchi P, Battisti F, Zappa M, Pattacini P, Campari C, Nitrosi A, Di Leo G, Frigerio A, Magni V, Fornasa F, Romanucci G, Falini P, Auzzi N, Armaroli P, Giorgi Rossi P; MAITA working group; Italian Breast Cancer Screening Guidelines working group. Djuric O, et al. Radiol Med. 2024 Sep;129(9):1288-1302. doi: 10.1007/s11547-024-01850-7. Epub 2024 Aug 20. Radiol Med. 2024. PMID: 39162938
1,570 results